title: Cefazolin plasma protein binding in different human populations: more than cefazolin-albumin interaction.
authors.affiliation: Neonatal Intensive Care Unit, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: anne.smits@uzleuven.be.
authors.forename: Anne
authors.initials: A
authors.lastname: Smits
authors.affiliation: Burns Trauma and Critical Care Research Centre, School of Medicine, The University of Queensland, Brisbane, Queensland, Australia; Royal Brisbane and Women's Hospital, Queensland, Australia.
authors.forename: Jason A
authors.initials: JA
authors.lastname: Roberts
authors.affiliation: Department of Clinical Pharmacology, Christchurch Hospital, Christchurch, New Zealand.
authors.forename: Jane W A
authors.initials: JW
authors.lastname: Vella-Brincat
authors.affiliation: Neonatal Intensive Care Unit, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium.
authors.forename: Karel
authors.initials: K
authors.lastname: Allegaert
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000378:metabolism* / Q000493:pharmacokinetics*; D002437:Cefazolin / Q000008:administration & dosage / Q000378:metabolism* / Q000493:pharmacokinetics*; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010949:Plasma / Q000737:chemistry*; D011247:Pregnancy; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism*; D000075462:Serum Albumin, Human
chemical_list: C422455:ALB protein, human; D000900:Anti-Bacterial Agents; D012709:Serum Albumin; D002437:Cefazolin; D000075462:Serum Albumin, Human